Second Degree Heart Block Risk Factors
Links shared publicly online about this topic
Patients With Non-ST-Elevation Acute Coronary Syndromes Treated With Otamixaban
medicalnewstoday.com — “Data from a phase ii trial of an investigational intravenous drug designed to block the formation of blood clots shows potential to reduce the risk of death, a second heart attack, or other corona” View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2009 at 2:52 pm By:
MNT Cardiovascular Health News
Patients With Non-ST-Elevation Acute Coronary Syndromes Treated With Otamixaban: Data from a phase II trial of a.. http://bit.ly/13Vgen
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Cardiovascular
The latest cardiovascular news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
